But her embrace of GLP-1 culture is a reminder that even the most untouchable of legends can be co-opted, and that in a society obsessed with shrinking, even our icons are made to disappear.
Here's what you need to know: Medicare Coverage (Effective Mid-2026) Following the November 2025 Trump administration agreements, Medicare will cover GLP-1 medications for obesity with: $50 monthly copay for eligible patients $245 government cost (down from $1,000+ list prices) Medicare Eligibility Requirements: BMI over 27 with prediabetes OR established cardiovascular disease, OR BMI over 30 with uncontrolled hypertension, kidney disease, or heart failure, OR BMI over 35 (severe obesity) Medicaid Coverage States can opt into $245 monthly pricing for all covered uses
The FDA has even warned about potential risks with compounded semaglutide, which include problems with online pharmacies, unsafe ingredients, and even fake versions of the drug
Shoulder - make a downward-facing triangle over the deltoid muscle on the upper arm with the thumb and forefinger of the non-injection hand
Market Factors Growth, Barriers, and Opportunity Analysis Rising Health Consciousness and Natural Product Preference Consumer awareness of the health benefits of yerba mate is a primary accelerator of market growth, particularly among consumers seeking natural, plant-based alternatives to conventional energy drinks
Sutapa Ghosh
